Hard-to-kill macrophages lead to chronic inflammation in HIV

[1]  J. Lieberman,et al.  Resistance of HIV-infected macrophages to CD8 T lymphocyte-mediated killing drives immune activation , 2018, Nature Immunology.

[2]  Ronald G. Collman,et al.  Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor , 2017, PLoS pathogens.

[3]  W. Lim,et al.  The Principles of Engineering Immune Cells to Treat Cancer , 2017, Cell.

[4]  M. Siedner,et al.  Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. , 2016, The Journal of infectious diseases.

[5]  Richard Jefferys,et al.  International AIDS Society global scientific strategy: towards an HIV cure 2016 , 2016, Nature Medicine.

[6]  R. Medzhitov,et al.  Tissue biology perspective on macrophages , 2015, Nature Immunology.

[7]  M. Robb,et al.  Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia , 2015, Journal of Virology.

[8]  Q. Sattentau,et al.  The HIV-1-containing macrophage compartment: a perfect cellular niche? , 2013, Trends in microbiology.

[9]  B. Haynes,et al.  Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection , 2012, Journal of Immunology.

[10]  J. Oxford,et al.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.

[11]  Mario Roederer,et al.  Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.

[12]  Youfang Cao,et al.  HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy , 2017 .